1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Olaptesed pegol - Monotherapy: new trials by email Literature Review of Olaptesed pegol - Monotherapy trials Research Report on Olaptesed pegol - Monotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Olaptesed (NOX-A12) Alone and in Combination With Pembrolizumab in Colorectal and Pancreatic Cancer Olaptesed pegol - Monotherapy, Olaptesed pegol + Pembrolizumab - Combination Therapy - Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer | Phase 1 / Phase 2 | Completed | TME Pharma AG | 20 | 2017-04-18 | 2020-07-08 |
Colorectal Neoplasms (1) · Pancreatic Neoplasms (1)
TME Pharma AG (1)
Germany (1)
2016 (1)